The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.
Open accessAbstract
BACKGROUND: Adjusting for large numbers of covariates ascertained from patients' health care claims data may improve control of confounding, as these variables may collectively be proxies for unobserved factors. Here, we develop and test an algorithm that empirically identifies candidate covariates, prioritizes covariates, and integrates them into a propensity-score-based confounder adjustment model. METHODS: We developed a multistep algorithm to implement high-dimensional proxy adjustment in claims data. Steps include (1) identifying data dimensions, eg, diagnoses, procedures, and medications; (2) empirically identifying candidate covariates; (3) assessing recurrence of codes; (4) prioritizing covariates; (5) selecting covariates for adjustment; (6) estimating the exposure propensity score; and (7) estimating an outcome model. This algorithm was tested in Medicare claims data, including a study on the effect of Cox-2 inhibitors on reduced gastric toxicity compared with nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). RESULTS: In a population of 49,653 new users of Cox-2 inhibitors or nonselective NSAIDs, a crude relative risk (RR) for upper GI toxicity (RR = 1.09 [95% confidence interval = 0.91-1.30]) was initially observed. Adjusting for 15 predefined covariates resulted in a possible gastroprotective effect (0.94 [0.78-1.12]). A gastroprotective effect became stronger when adjusting for an additional 500 algorithm-derived covariates (0.88 [0.73-1.06]). Results of a study on the effect of statin on reduced mortality were similar. Using the algorithm adjustment confirmed a null finding between influenza vaccination and hip fracture (1.02 [0.85-1.21]). CONCLUSIONS: In typical pharmacoepidemiologic studies, the proposed high-dimensional propensity score resulted in improved effect estimates compared with adjustment limited to predefined covariates, when benchmarked against results expected from randomized trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This algorithm leverages that large volumes of covariates can collectively serve as good proxies for unmeasured confounders and thus produce results from observational data that more closely resemble results from randomization.42”
From Hysterectomy versus uterine preservation for pelvic organ prolapse surgery: a prospective cohort study (2025) · cites this paper as [42]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · RePEc: Research Papers in Economics · Cited by 27,577
Revisiting the Behavioral Model and Access to Medical Care: Does it Matter?
Andersen, R. M. (1995) · Journal of Health and Social Behavior · doi:10.2307/2137284 · Cited by 9,831
Variable Selection for Propensity Score Models
Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj149 · Cited by 2,336
Self-citationEvaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
A review of uses of health care utilization databases for epidemiologic research on therapeutics
Schneeweiß, S., & Avorn, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.012 · Cited by 1,290
Self-citationHirano, K., & Imbens, G. W. (2001) · Health Services and Outcomes Research Methodology · doi:10.1023/a:1020371312283 · Cited by 1,039
Unified Methods for Censored Longitudinal Data and Causality
van der Laan, M. J., & Robins, J. M. (2003) · Springer series in statistics · doi:10.1007/978-0-387-21700-0 · Cited by 979
Quantifying Biases in Causal Models: Classical Confounding vs Collider-Stratification Bias
Greenland, S. (2003) · Epidemiology · doi:10.1097/01.ede.0000042804.12056.6c · Cited by 810
Stürmer, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiß, S. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 668
Self-citationSolomon, D. H., Schneeweiß, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H., & Avorn, J. (2004) · Circulation · doi:10.1161/01.cir.0000127578.21885.3e · Cited by 506
Self-citation
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Arana, 2004, What do we show and who does so? An analysis of the abstracts presented at the 19th ICPE., Pharmacoepidemiol Drug Saf, 13, S330
Cited by
Sorted by citations
Items 401–500 of 1,000
Propensity score methods in real‐world epidemiology: A practical guide for first‐time users
Loke, Y. K., & Mattishent, K. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13926 · Cited by 26
Desai, R. J., Varma, V. R., Gerhard, T., Segal, J. B., Mahesri, M., Chin, K., Nonnenmacher, E., Gabbeta, A., Oommen, A. M., Varma, S., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12095 · Cited by 26
Patorno, E., Glynn, R. J., Hernández–Dı́az, S., Avorn, J., Wahl, P. M., Bohn, R. L., Mines, D. I., Liu, J., & Schneeweiß, S. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000208 · Cited by 26
Self-citationSmith, E. G., Austin, K., Kim, H. M., Eisen, S. V., Kilbourne, A. M., Miller, D. R., Zivin, K., Hannemann, C. M., Sauer, B. C., & Valenstein, M. M. (2015) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.138685 · Cited by 26
Performance of the High‐dimensional Propensity Score in a Nordic Healthcare Model
Hallas, J., & Pottegård, A. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12716 · Cited by 26
El-Refai, S. M., Brown, J. D., Arnold, S. M., Black, E. P., Leggas, M. L., & Talbert, J. (2017) · JCO Clinical Cancer Informatics · doi:10.1200/cci.17.00010 · Cited by 27
Basham, C. A., Karim, M. E., Cook, V. J., Patrick, D. M., & Johnston, J. C. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100752 · Cited by 27
The use of clinical trials in comparative effectiveness research on mental health
Blanco, C., Rafful, C. M., & Olfson, M. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.013 · Cited by 25
Bleecker, E. R., Blaiss, M. S., Jacob-Nara, J. A., Huynh, L. Y., Duh, M. S., Guo, T., Ye, M., Stanford, R. H., Wang, Z., Soler, X., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.07.029 · Cited by 25
Rassen, J. A., Solomon, D. H., Glynn, R. J., & Schneeweiß, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2121 · Cited by 25
Self-citationHuybrechts, K. F., Brookhart, M. A., Rothman, K. J., Silliman, R. A., Gerhard, T., Crystal, S., & Schneeweiß, S. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr213 · Cited by 25
Self-citationReuse of data sources to evaluate drug safety signals: When is it appropriate?
Wang, S. V., Kulldorff, M., Glynn, R. J., Gagne, J. J., Pottegård, A., Rothman, K. J., Schneeweiß, S., & Walker, A. M. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4442 · Cited by 25
Self-citationLyu, B., Chan, M. R., Yevzlin, A. S., Gardezi, A. I., & Astor, B. C. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.03.030 · Cited by 25
Transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting
Tazare, J., Wyss, R., Franklin, J. M., Smeeth, L. L., Evans, S. J. W., Wang, S. V., Schneeweiß, S., Douglas, I., Gagne, J. J., & Williamson, E. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5412 · Cited by 25
Rodríguez, C. L., Kaas‐Hansen, B. S., Eriksson, R., Biel, J. H., Belling, K., Andersen, S. E., & Brunak, S. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5415 · Cited by 28
Wong, J., Prieto‐Alhambra, D., Rijnbeek, P. R., Desai, R. J., Reps, J., & Toh, S. (2022) · Drug Safety · doi:10.1007/s40264-022-01158-3 · Cited by 25
Lee, Y. H. A., Zhou, J., Hui, J. M. H., Liu, X., Lee, T. T. L., Hui, K., Chan, J. S. K., Wai, A. K. C., Wong, W. T., Liu, T., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.7010 · Cited by 25
Shin, J., Choi, N., Lee, J., Seong, J.-M., Park, M.-J., Lee, S. H., & Park, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119931 · Cited by 25
Hospitalization for Hemorrhage Among Warfarin Recipients Prescribed Amiodarone
Lam, J., Gomes, T., Juurlink, D. N., Mamdani, M., Pullenayegum, E., Kearon, C., Spencer, F. A., Paterson, M. J., Zheng, H. Y., & Holbrook, A. M. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.03.051 · Cited by 25
Fullerton, B., Pöhlmann, B., Krohn, R., Adams, J., Gerlach, F. M., & Erler, A. (2016) · Health Services Research · doi:10.1111/1475-6773.12452 · Cited by 25
Shewale, A. R., Barnes, C. L., Fischbach, L. A., Ounpraseuth, S., Painter, J. T., & Martin, B. C. (2017) · The Journal of Arthroplasty · doi:10.1016/j.arth.2017.07.007 · Cited by 25
Degree of serotonin reuptake inhibition of antidepressants and ischemic risk
Douros, A., Dell’Aniello, S., Dehghan, G., Boivin, J., & Renoux, C. (2019) · Neurology · doi:10.1212/wnl.0000000000008060 · Cited by 26
Retail clinic utilization associated with lower total cost of care.
Sussman, A. J., Dunham, L. N., Snower, K., Hu, M., Matlin, O. S., Shrank, W. H., Choudhry, N. K., & Brennan, T. A. (2013) · PubMed · Cited by 25
Funch, D., Mortimer, K., Ziyadeh, N. J., Seeger, J. D., Zhou, L., Ng, E., Ross, D., Major-Pedersen, A., Bosch-Traberg, H., Gydesen, H., et al. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s305496 · Cited by 24
Crisafulli, S., Ciccimarra, F., Bellitto, C., Carollo, M., Carrara, E., Stagi, L., Triola, R., Capuano, A., Chiamulera, C., Moretti, U., et al. (2024) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2024.1356405 · Cited by 29
Simon, T. G., Singer, D. E., Zhang, Y., Mastrorilli, J. M., Cervone, A., DiCesare, E., & Lin, K. J. (2024) · Annals of Internal Medicine · doi:10.7326/m23-3067 · Cited by 24
Yoon, H., Kim, H., Bae, Y., & Song, J. W. (2024) · European Respiratory Journal · doi:10.1183/13993003.01484-2024 · Cited by 24
Assessing Covariate Balance With Small Sample Sizes
Hripcsak, G. M., Zhang, L., Chen, Y., Li, K., Suchard, M. A., Ryan, P. B., & Schuemie, M. J. (2025) · Statistics in Medicine · doi:10.1002/sim.70212 · Cited by 24
Gamble, J., Donnan, J. R., Chibrikov, E., Twells, L., Midodzi, W. K., & Majumdar, S. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-33483-y · Cited by 24
Desai, R. J., Patorno, E., Vaduganathan, M., Mahesri, M., Chin, K., Levin, R., Solomon, S. D., & Schneeweiß, S. (2021) · Heart · doi:10.1136/heartjnl-2021-319405 · Cited by 24
Zhou, J., Lee, S., Lakhani, I., Yang, L., Liu, T., Zhang, Y., Xia, Y., Wong, W. T., Bao, K. K. H., Wong, I. C. K., et al. (2022) · Cardio-Oncology · doi:10.1186/s40959-021-00128-5 · Cited by 24
Covariate Selection in Propensity Scores Using Outcome Proxies
Kelcey, B. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.570164 · Cited by 24
Neugebauer, R. S., FIREMAN, B. H., Roy, J. A., Raebel, M. A., Nichols, G. A., & O’Connor, P. J. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.01.016 · Cited by 25
Smith, E. G., Austin, K., Kim, H. M., Miller, D. R., Eisen, S. V., Christiansen, C. L., Kilbourne, A. M., Sauer, B. C., McCarthy, J. F., & Valenstein, M. M. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0357-x · Cited by 24
Le, H. V., Poole, C., Brookhart, M. A., Schoenbach, V. J., Beach, K. J., Layton, J. B., & Stürmer, T. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-142 · Cited by 24
Self-citationPregabalin and heart failure: A population‐based study
Ho, J. M.-W., Macdonald, E. M., Luo, J., Gomes, T., Antoniou, T., Mamdani, M., & Juurlink, D. N. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4239 · Cited by 24
Recent Methodological Trends in Epidemiology: No Need for Data-Driven Variable Selection?
Staerk, C., Byrd, A., & Mayr, A. J. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad193 · Cited by 23
Højlund, M., Wesselhoeft, R. T., Heinrichsen, M., Pagsberg, A. K., Correll, C. U., & Steinhausen, H. (2025) · World Psychiatry · doi:10.1002/wps.21279 · Cited by 23
“Weekend effect” on stroke mortality revisited
Hsieh, C., Lin, H., Chen, C., Li, C., Chiu, M.-J., & Sung, S. (2016) · Medicine · doi:10.1097/md.0000000000004046 · Cited by 23
Chen, Y., Zhou, J., Li, G., Tong, Z., Dong, J., Pan, Y., Ke, L., Li, W., & Li, J. (2017) · Scientific Reports · doi:10.1038/srep42607 · Cited by 23
Blin, P., Fauchier, L., Dureau-Pournin, C., Sacher, F., Dallongeville, J., Bernard, M., Lassalle, R., Droz‐Perroteau, C., & Moore, N. D. (2019) · Stroke · doi:10.1161/strokeaha.119.025824 · Cited by 23
In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners
Singal, D., Chateau, D. G., Struck, S., Lee, J. B., Dahl, M. E., Derksen, S., Katz, L. Y., Ruth, C., Hanlon‐Dearman, A., & Brownell, M. D. (2020) · PEDIATRICS · doi:10.1542/peds.2019-1157 · Cited by 23
Ashley, J., McArthur, E., Bota, S. E., Harel, Z., Battistella, M., Molnar, A. O., Jun, M., Badve, S. V., Garg, A. X., Manuel, D. G., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.02.446 · Cited by 23
Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study
Abrahami, D., Pradhan, R., Yin, H., Yanofsky, R. P., McDonald, E. G., Bitton, A., & Azoulay, L. (2023) · Gut · doi:10.1136/gutjnl-2022-328866 · Cited by 23
Kjerpeseth, L. J., Cesta, C. E., Furu, K., Engeland, A., Gissler, M., Gulseth, H. L., Karlstad, Ø., Leinonen, M. K., Pazzagli, L., Zoëga, H., et al. (2023) · Diabetes Care · doi:10.2337/dc23-0256 · Cited by 24
Acton, E. K., Hennessy, S., Gelfand, M. A., Leonard, C. E., Bilker, W. B., Shu, D., Willis, A. W., & Kasner, S. E. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.2057 · Cited by 23
Brüggenjürgen, B., Andersohn, F., Ezzat, N., Lacey, L. A., & Willich, S. N. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1014090 · Cited by 23
Wu, A. C., Li, L., Fung, V., Kharbanda, E. O., Larkin, E. K., Vollmer, W. M., Butler, M. G., Miroshnik, I. L., Rusinak, D., Davis, R. L., et al. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.05.009 · Cited by 23
Real-World Data Analytics Fit for Regulatory Decision-Making
Schneeweiß, S., & Glynn, R. J. (2018) · American Journal of Law & Medicine · doi:10.1177/0098858818789429 · Cited by 23
Self-citationCarnide, N., Hogg‐Johnson, S., Koehoorn, M. W., Furlan, A. D., & Côté, P. (2019) · Occupational and Environmental Medicine · doi:10.1136/oemed-2018-105626 · Cited by 23
E-Synthesis: A Bayesian Framework for Causal Assessment in Pharmacosurveillance
Pretis, F. D., Landes, J., & Osimani, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01317 · Cited by 24
Toh, S. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1754 · Cited by 23
Association between myelofibrosis and thromboembolism: A population‐based retrospective cohort study
Saliba, W., Mishchenko, E., Cohen, S., Rennert, G., & Preis, M. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14754 · Cited by 23
Comparison of Calipers for Matching on the Disease Risk Score
Connolly, J. G., & Gagne, J. J. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv302 · Cited by 22
Neugebauer, R. S., Schroeder, E. B., Reynolds, K., Schmittdiel, J. A., Loes, L., Dyer, W., DESAI, J. R., Vazquez‐Benitez, G., Ho, P. M., Anderson, J. P., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.18554 · Cited by 22
Bowie, A. C., Werler, M. M., Vélez, M. P., Li, W., Camden, A., Guttmann, A., & Brogly, S. B. (2022) · Canadian Medical Association Journal · doi:10.1503/cmaj.211215 · Cited by 22
Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning
Courtois, É., Nguyen, T. T. H., Fournier, A., Carcaillon‐Bentata, L., Moutengou, E., Escolano, S., Tubert‐Bitter, P., Elbaz, A., Thiébaut, A. C. M., & Ahmed, I. (2022) · Movement Disorders · doi:10.1002/mds.29205 · Cited by 22
Peng, Z., Yang, C., Kuo, S., Wu, C., Lin, W., & Ou, H. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.46928 · Cited by 23
Effectiveness and safety of empagliflozin: final results from the EMPRISE study
Htoo, P. T., Tesfaye, H., Schneeweiß, S., Wexler, D. J., Everett, B. M., Glynn, R. J., Schmedt, N., Koeneman, L., Déruaz‐Luyet, A., Paik, J. M., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06126-3 · Cited by 22
Self-citationPropensity Score Methods and Unobserved Covariate Imbalance: Comments on “Squeezing the Balloon”
Ali, M. S., Groenwold, R. H. H., & Klungel, O. H. (2014) · Health Services Research · doi:10.1111/1475-6773.12152 · Cited by 22
Predicting 1-Year Statin Adherence Among Prevalent Users: A Retrospective Cohort Study
Krumme, A. A., Franklin, J. M., Isaman, D. L., Matlin, O. S., Tong, A. Y., Spettell, C. M., Brennan, T. A., Shrank, W. H., & Choudhry, N. K. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.4.494 · Cited by 22
Ishimaru, M., Ono, S., Matsui, H., & Yasunaga, H. (2019) · Clinical Oral Investigations · doi:10.1007/s00784-018-2783-5 · Cited by 22
Big data and real-world data-based medicine in the management of hypertension
Okada, M. (2020) · Hypertension Research · doi:10.1038/s41440-020-00580-3 · Cited by 24
Garbe, E., & Suissa, S. (2013) · Springer eBooks · doi:10.1007/978-0-387-09834-0_31 · Cited by 22
Platt, R. W., Dormuth, C. R., Chateau, D. G., & Filion, K. B. (2016) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.13063/2327-9214.1221 · Cited by 21
Connolly, J. G., Wang, S. V., Fuller, C. C., Toh, S., Panozzo, C. A., Cocoros, N. M., Zhou, M., Gagne, J. J., & Maro, J. C. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0121-0 · Cited by 21
Palzes, V. A., Farokhnia, M., Kline‐Simon, A. H., Elson, J., Sterling, S., Leggio, L., Weisner, C. M., & Chi, F. W. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01117-z · Cited by 21
Research and scholarly methods: Propensity scores
Medaglio, D., Stephens‐Shields, A. J., & Leonard, C. E. (2022) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1591 · Cited by 22
Chen, Q., Hu, A., Ma, A., Jiang, F., Xiao, Y., Chen, Y., Huang, R., Yang, T., & Zhou, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.813682 · Cited by 21
Wyss, R., Yanover, C., El‐Hay, T., Bennett, D., Platt, R. W., Zullo, A. R., Sari, G., Wen, X., Ye, Y., Yuan, H., et al. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5500 · Cited by 22
Luijken, K., van EEKELEN, R., Gardarsdóttir, H., Groenwold, R. H. H., & van Geloven, N. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5620 · Cited by 21
Peng, Z., Yang, C.-T., Lin, W., Yao, W., Ou, H., & Kuo, S. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01991-5 · Cited by 21
Analyzing patterns of drug use in clinical notes for patient safety.
LePendu, P., Liu, Y., Iyer, S. V., Udell, M. R., & Shah, N. H. (2012) · Europe PMC (PubMed Central) · Cited by 21
Near-Real-Time Monitoring of New Drugs: An Application Comparing Prasugrel Versus Clopidogrel
Gagne, J. J., Rassen, J. A., Choudhry, N. K., Bohn, R. L., Patrick, A. R., Sridhar, G., Daniel, G. W., Liu, J., & Schneeweiß, S. (2014) · Drug Safety · doi:10.1007/s40264-014-0136-0 · Cited by 21
Self-citationPang, M., Schuster, T., Filion, K. B., Schnitzer, M. E., Eberg, M., & Platt, R. W. (2016) · The International Journal of Biostatistics · doi:10.1515/ijb-2015-0034 · Cited by 21
A General Propensity Score for Signal Identification Using Tree-Based Scan Statistics
Wang, S. V., Maro, J. C., Gagne, J. J., Patorno, E., Sreedhara, S. K., Stojanović, D., Eworuke, E., Baro, E., Ouellet‐Hellstrom, R., Nguyen, M., et al. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwab034 · Cited by 20
Association of Low-Dose Quetiapine and Diabetes
Højlund, M., Lund, L. C., Andersen, K., Correll, C. U., & Hallas, J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.3209 · Cited by 20
Liang, D., Gardella, E., Kragholm, K. H., Polcwiartek, C., & Sessa, M. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.07.020 · Cited by 20
Baum, U., Kulathinal, S., & Auranen, K. J. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.36.2100054 · Cited by 20
Benasseur, I., Talbot, D. C., Durand, M., Holbrook, A. M., Matteau, A., Potter, B. J., Renoux, C., Schnitzer, M. E., Tarride, J., & Guertin, J. R. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5403 · Cited by 20
Wong, M. C. S., Tam, W., Lao, X. Q., Wang, H., Kwan, M. W. M., Cheung, C. S. K., Tong, E. L. H., Cheung, N. T., Griffiths, S. M., & Coats, A. J. S. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.028 · Cited by 20
Huang, Y., Abdelmoneim, A. S., Light, P. E., Qiu, W., & Simpson, S. H. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.11.012 · Cited by 21
Comparative effectiveness research: what is it and why do we need it in nephrology?
Chang, T. I., & Winkelmayer, W. C. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs154 · Cited by 20
Incentive-Based Primary Care: Cost and Utilization Analysis
Hollander, M. J., & Kadlec, H. (2015) · The Permanente Journal · doi:10.7812/tpp/15-045 · Cited by 20
Abdelmoneim, A. S., Eurich, D. T., Senthilselvan, A., Qiu, W., & Simpson, S. H. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4014 · Cited by 20
Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
Fisher, A., Hudson, M., Platt, R. W., & Dormuth, C. R. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.191252 · Cited by 20
Vajravelu, R. K., Shapiro, J. M., Ni, J., Thanawala, S. U., Lewis, J. D., & El‐Serag, H. B. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.08.049 · Cited by 20
Evaluating A Nonemergency Medical Transportation Benefit For Accountable Care Organization Members
Berkowitz, S. A., Ricks, K. A. B., Wang, J., Parker, M., Rimal, R., & DeWalt, D. A. (2022) · Health Affairs · doi:10.1377/hlthaff.2021.00449 · Cited by 20
Schuster, T., Pang, M., & Platt, R. W. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3773 · Cited by 20
FLAME: A Fast Large-scale Almost Matching Exactly Approach to Causal InferencePreprint
Wang, T., Morucci, M., Awan, M. U., Liu, Y., Roy, S., Rudin, C. D., & Volfovsky, A. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1707.06315 · Cited by 22
Straub, L., Bateman, B. T., Hernández–Dı́az, S., Zhu, Y., Suarez, E. A., Vine, S. M., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., et al. (2024) · JAMA · doi:10.1001/jama.2024.11501 · Cited by 19
Self-citationLeonard, C. E., Brensinger, C. M., Dawwas, G. K., Deo, R., Bilker, W. B., Soprano, S. E., Dhopeshwarkar, N., Flory, J., Bloomgarden, Z. T., Gagne, J. J., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-00999-5 · Cited by 20
Rea, F., Ronco, R., Pedretti, R. F. E., Merlino, L. G., & Corrao, G. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.06.017 · Cited by 19
Sarayani, A., Winterstein, A., Cristofoletti, R., Vozmediano, V., Schmidt, S., & Brown, J. D. (2023) · Contraception · doi:10.1016/j.contraception.2023.109953 · Cited by 19
Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System
Suarez, E. A., Nguyen, M., Zhang, D., Zhao, Y., Stojanović, D., Muñoz, M. A., Liedtka, J., Anderson, A., Liu, W., Dashevsky, I., et al. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5512 · Cited by 19
Tu, L., Navaratnam, D. S., Melnick, E. R., Forman, H. P., Venkatesh, A. K., Malhotra, A., Yaesoubi, R., Sureshanand, S., Sheth, K. N., & Mahajan, A. K. (2023) · American Journal of Roentgenology · doi:10.2214/ajr.23.29617 · Cited by 19
Beneficiaries With Cardiovascular Disease and the Part D Coverage Gap
Polinski, J. M., Shrank, W. H., Glynn, R. J., Huskamp, H. A., Roebuck, M. C., & Schneeweiß, S. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.964866 · Cited by 19
Self-citationAskgaard, G., Hallas, J., Fink‐Jensen, A., Molander, A., Madsen, K. G., & Pottegård, A. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.016 · Cited by 19
Increased risk of ischemic stroke in patients with burn injury: a nationwide cohort study in Taiwan
Hung, T., Lee, Y., Huang, M.-Y., Hsu, C.-Y., & Su, Y. (2016) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/s13049-016-0236-1 · Cited by 19
A Review of Disease Risk Scores and Their Application in Pharmacoepidemiology
Wyss, R., Glynn, R. J., & Gagne, J. J. (2016) · Current Epidemiology Reports · doi:10.1007/s40471-016-0088-2 · Cited by 19
Self-citation
Metadata
- Authors
- Schneeweiss, S., Rassen, J. A., Glynn, R. J., Avorn, J., Mogun, H., & Brookhart, M. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Schneeweiss, Sebastian
- Venue
- Epidemiology
- Published
- 2009-07
- Volume
- 20
- Issue
- 4
- Pages
- 512-522
- ISSN
- 1044-3983 (ISSN-L)
- PMC
- PMC3077219
- OpenAlex
- W1967862917
- Cited by
- 1,128
- References
- 44
- Citations by year
- 2026: 51 · 2025: 78 · 2024: 77 · 2023: 62 · 2022: 71 · 2021: 104 · 2020: 87 · 2019: 86 · 2018: 69 · 2017: 73 · 2016: 72 · 2015: 62 · 2014: 61 · 2013: 66 · 2012: 55
- FWCI
- 29.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1r01lm010213-01)
- National Institute on Aging (R01AG021950, R01-AG027400, K25AG027400, R01AG018833, R01AG023178)
- National Institute of Mental Health (R01-MH078708, U01MH078708)
- U.S. National Library of Medicine (R01-LM010213)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Health Sciences › Health Professions › Health Information Management › Medical Coding and Health Information
- Keywords
- high-dimensional propensity score, confounding adjustment, health insurance claims, COX-2 inhibitors, non-selective NSAIDs, influenza vaccination, hip fracture, Medicare claims data, pharmacoepidemiology
- MeSH terms
- Aged, Aged, 80 and over, Algorithms, Anti-Inflammatory Agents, Non-Steroidal, Female, Medicare, Humans, Insurance Claim Review, Male, United States, Confounding Factors, Epidemiologic, Treatment Outcome, Pharmacoepidemiology, Risk Assessment, Upper Gastrointestinal Tract, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review